Chemical equilibration of quarks and gluons at RHIC and LHC energies

We study chemical equilibration of quarks and gluons in central nuclear collisions at RHIC and LHC energies. The initial quark and gluon densities are taken from earlier studies as well as from recent perturbative QCD estimates and are then evolved via rate equations coupled to longitudinally boost-invariant fluid dynamics. We find that, for RHIC initial conditions, the lifetime of quark-gluon matter is too short in order for the quark and gluon number densities to chemically equilibrate prior to hadronization. In contrast, at LHC energies chemical equilibration is complete before the system hadronizes. Entropy production due to chemical equilibration can be as large as 30%.Comment: 30 pages (latex2e), 13 postscript figures, corrected one figure, further analysis performed, to be published in NP

Space-time evolution and HBT analysis of relativistic heavy ion collisions in a chiral SU(3) x SU(3) model

The space-time dynamics and pion-HBT radii in central heavy ion-collisions at CERN-SPS and BNL-RHIC are investigated within a hydrodynamic simulation. The dependence of the dynamics and the HBT-parameters on the EoS is studied with different parametrisations of a chiral SU(3) sigma-omega model. The selfconsistent collective expansion includes the effects of effective hadron masses, generated by the nonstrange and strange scalar condensates. Different chiral EoS show different types of phase transitions and even a crossover. The influence of the order of the phase transition and of the difference in the latent heat on the space-time dynamics and pion-HBT radii is studied. A small latent heat, i.e. a weak first-order chiral phase transition, or even a smooth crossover leads to distinctly different HBT predictions than a strong first order phase transition. A quantitative description of the data, both at SPS energies as well as at RHIC energies, appears difficult to achieve within the ideal hydrodynamical approach using the SU(3) chiral EoS. A strong first-order quasi-adiabatic chiral phase transition seems to be disfavored by the pion-HBT data from CERN-SPS and BNL-RHIC

Dynamics of Hot Bulk QCD Matter: from the Quark-Gluon Plasma to Hadronic Freeze-Out

We introduce a combined macroscopic/microscopic transport approach employing relativistic hydrodynamics for the early, dense, deconfined stage of the reaction and a microscopic non-equilibrium model for the later hadronic stage where the equilibrium assumptions are not valid anymore. Within this approach we study the dynamics of hot, bulk QCD matter, which is expected to be created in ultra-relativistic heavy ion collisions at the SPS, the RHIC and the LHC. Our approach is capable of self-consistently calculating the freeze-out of the hadronic system, while accounting for the collective flow on the hadronization hypersurface generated by the QGP expansion. In particular, we perform a detailed analysis of the reaction dynamics, hadronic freeze-out, and transverse flow.Comment: 55 pages, 15 figure

Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors

Context Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene are responsible for a subset of familial isolated pituitary adenoma (FIPA) cases and sporadic pituitary neuroendocrine tumors (PitNETs). Objective To compare prospectively diagnosed AIP mutation-positive (AIPmut) PitNET patients with clinically presenting patients and to compare the clinical characteristics of AIPmut and AIPneg PitNET patients. Design 12-year prospective, observational study. Participants & Setting We studied probands and family members of FIPA kindreds and sporadic patients with disease onset ≤18 years or macroadenomas with onset ≤30 years (n = 1477). This was a collaborative study conducted at referral centers for pituitary diseases. Interventions & Outcome AIP testing and clinical screening for pituitary disease. Comparison of characteristics of prospectively diagnosed (n = 22) vs clinically presenting AIPmut PitNET patients (n = 145), and AIPmut (n = 167) vs AIPneg PitNET patients (n = 1310). Results Prospectively diagnosed AIPmut PitNET patients had smaller lesions with less suprasellar extension or cavernous sinus invasion and required fewer treatments with fewer operations and no radiotherapy compared with clinically presenting cases; there were fewer cases with active disease and hypopituitarism at last follow-up. When comparing AIPmut and AIPneg cases, AIPmut patients were more often males, younger, more often had GH excess, pituitary apoplexy, suprasellar extension, and more patients required multimodal therapy, including radiotherapy. AIPmut patients (n = 136) with GH excess were taller than AIPneg counterparts (n = 650). Conclusions Prospectively diagnosed AIPmut patients show better outcomes than clinically presenting cases, demonstrating the benefits of genetic and clinical screening. AIP-related pituitary disease has a wide spectrum ranging from aggressively growing lesions to stable or indolent disease course

Clinical phenotype and linkage analysis of the congenital fibrosis of the extraocular muscles in an Indian family

Purpose: To describe the clinical phenotype and linkage analysis of the congenital fibrosis of the extraocular muscles (CFEOM) in an Indian family. Methods: Individuals were examined and their peripheral blood samples were withdrawn for genetic analysis. The disorder was tested for linkage to two known autosomal dominant CFEOM loci on chromosome 12p11.2-q12 (CFEOM1) and chromosome 16q24 (CFEOM3) using microsatellite markers. Results: Nine individuals including seven affecteds participated in the study. All seven affecteds had a classic form of CFEOM which included congenital bilateral ptosis, hypotropia, and chin elevation. The disorder segregated as an autosomal dominant trait in this family. The maximum simulated lod score in this family was 2.02. Linkage to CFEOM3 was excluded (Z<-2.00), whereas analysis of chromosome 12 markers was positive. The maximum observed two-point lod score was 1.8 (given the size and structure of the family) at theta=0 with marker D12S345. Markers D12S61, D12S1631,D12S87, D12S345, D12S59, D12S1048, and D12S1668 cosegregated with the disease locus in all affecteds. Haplotype analysis showed that the candidate region spanned the centromere. Conclusions: The present data showed a classic CFEOM phenotype in an Indian family. The family’s phenotype is consistent with linkage to CFEOM1 locus on chromosome 12p11.2-q12